Article
Tackling Cancer Stem Cells via Inhibition of EMT Transcription Factors
1 Jan 2016
Abstract excerpt
Cancer stem cell (CSC) has become recognized for its role in both tumorigenesis and poor patient prognosis in recent years. Traditional therapeutics are unable to effectively eliminate this group of cells from the bulk population of cancer cells, allowing CSCs to persist posttreatment and thus propagate into secondary tumors. The therapeutic potential of eliminating CSCs, to decrease tumor relapse, has created a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
